Therapeutic HPV16 vaccines

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9701721
APP PUB NO 20160122396A1
SERIAL NO

14932789

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided is designer nucleic acid constructs and polypeptides that can be used as therapeutic vaccines against HPV16.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
JANSSEN VACCINES & PREVENTION B V2333 CN LEIDEN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bunnik, Evelien Margaretha Riverside, US 5 28
Custers, Jerome Hubertina Henricus Victor Alphen aan den Rijn, NL 9 27
Khan, Selina Leiden, NL 18 66
Oosterhuis, Koen Haarlem, NL 8 38
Scheper, Gerrit Christiaan Amstelveen, NL 6 28
Uil, Taco Gilles Amsterdam, NL 16 41

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 11, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 11, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00